Art

J-GLOBAL ID：201502206118005837   Reference number：15A0937031

新たな抗体治療の展開 新たに開発された抗体治療 乳がん

Author (7)： MASUDA JUN (虎の門病院 臨床腫瘍科) ,  UCHIYAMA MIYUKI (虎の門病院 臨床腫瘍科) ,  KOGANEMARU SHIGEHIRO (虎の門病院 臨床腫瘍科) ,  OZAKI YUKINORI (虎の門病院 臨床腫瘍科) ,  TANABE YUKO (虎の門病院 臨床腫瘍科) ,  MIURA YUJI (虎の門病院 臨床腫瘍科) ,  TAKANO TOSHIMI (虎の門病院 臨床腫瘍科)
Material： がん分子標的治療  (Journal of Molecular Targeted Therapy for Cancer)
Volume： 13  Issue： 2  Page： 172-179  Publication year： Jul. 24, 2015 
JST Material Number： L5138A  ISSN： 1347-6955  Document type： Article
Article type： 解説  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： human(primates) ,...
Semi thesaurus term： グレンバツムマブベドチン ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=15A0937031&from=J-GLOBAL&jstjournalNo=L5138A") }}

JST classification (2)： Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L)

Substance index (1)： Lapatinib

Reference (47)：

• Perez EA, Romond EH, Suman VJ, et al : Four-year follow-up of trastuzumab plus adjuvant chemotherapy for operable human epidermal growth factor receptor 2-positive breast cancer ; joint analysis of data from NCCTG N9831 and NSABP B-31. J Clin Oncol 29 : 3366-3373, 2011
• Gianni L, Dafni U, Gelber RD, et al ; Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer ; a 4-year follow-up of a randomised controlled trial. Lancet Oncol 12 : 236-244, 2011
• Slamon D, Eiermann W, Robert N, et al : Adjuvant trastuzumab in HER2-positive breast cancer. N Engl J Med 365 : 1273-1283, 2011
• Joensuu H, Bono P, Kataja V, et al : Fluorouracil, epirubicin, and cyclo-phosphamide with either docetaxel or vinorelbine, with or without trastuzumab, as adjuvant treatments of breast cancer ; final results of the FinHer Trial. J Clin Oncol 27 : 5685-5692, 2009
• Moja L, Tagliabue L, Balduzzi S, et al : Trastuzumab containing regimens for early breast cancer. Cochrane Database Syst Rev 4 CD006243, 2012

Terms in the title (5)： 抗体 ,  治療 ,  展開 ,  開発 ,  乳がん